Literature DB >> 19505912

Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry.

Kelly-Anne Phillips1, Roger L Milne, Dee W West, Pamela J Goodwin, Graham G Giles, Ellen T Chang, Jane C Figueiredo, Michael L Friedlander, Theresa H M Keegan, Gord Glendon, Carmel Apicella, Frances P O'Malley, Melissa C Southey, Irene L Andrulis, Esther M John, John L Hopper.   

Abstract

Studies have examined the prognostic relevance of reproductive factors before breast cancer diagnosis, but most have been small and their overall findings inconclusive. Associations between reproductive risk factors and all-cause mortality after breast cancer diagnosis were assessed with the use of a population-based cohort of 3,107 women of White European ancestry with invasive breast cancer (1,130 from Melbourne and Sydney, Australia; 1,441 from Ontario, Canada; and 536 from Northern California, United States). During follow-up with a median of 8.5 years, 567 deaths occurred. At recruitment, questionnaire data were collected on oral contraceptive use, number of full-term pregnancies, age at first full-term pregnancy, time from last full-term pregnancy to breast cancer diagnosis, breastfeeding, age at menarche, and menopause and menopausal status at breast cancer diagnosis. Hazard ratios for all-cause mortality were estimated with the use of Cox proportional hazards models with and without adjustment for age at diagnosis, study center, education, and body mass index. Compared with nulliparous women, those who had a child up to 2 years, or between 2 and 5 years, before their breast cancer diagnosis were more likely to die. The unadjusted hazard ratio estimates were 2.75 [95% confidence interval (95% CI), 1.98-3.83; P < 0.001] and 2.20 (95% CI, 1.65-2.94; P < 0.001), respectively, and the adjusted estimates were 2.25 (95% CI, 1.59-3.18; P < 0.001) and 1.82 (95% CI, 1.35-2.46; P < 0.001), respectively. When evaluating the prognosis of women recently diagnosed with breast cancer, the time since last full-term pregnancy should be routinely considered along with other established host and tumor prognostic factors, but consideration of other reproductive factors may not be warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19505912      PMCID: PMC2746957          DOI: 10.1158/1055-9965.EPI-08-1014

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  26 in total

1.  Reproducibility and validity of maternal recall of pregnancy-related events.

Authors:  C A Tomeo; J W Rich-Edwards; K B Michels; C S Berkey; D J Hunter; A L Frazier; W C Willett; S L Buka
Journal:  Epidemiology       Date:  1999-11       Impact factor: 4.822

2.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group.

Authors:  D F Easton; J Peto; A G Babiker
Journal:  Stat Med       Date:  1991-07       Impact factor: 2.373

3.  Children, family and cancer survival in Norway.

Authors:  Øystein Kravdal
Journal:  Int J Cancer       Date:  2003-06-10       Impact factor: 7.396

4.  Risk factors and 10-year breast cancer survival in northern Alberta.

Authors:  A W Lees; H J Jenkins; C L May; G Cherian; E W Lam; J Hanson
Journal:  Breast Cancer Res Treat       Date:  1989-03       Impact factor: 4.872

5.  The relation of reproductive factors to mortality from breast cancer.

Authors:  Janet R Daling; Kathleen E Malone; David R Doody; Benjamin O Anderson; Peggy L Porter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-03       Impact factor: 4.254

6.  Parity confers better prognosis in older women with early-stage breast cancer treated with breast-conserving therapy.

Authors:  Penny R Anderson; Alexandra L Hanlon; Gary M Freedman; Nicos Nicolaou
Journal:  Clin Breast Cancer       Date:  2004-08       Impact factor: 3.225

7.  Reproductive history and mortality after breast cancer diagnosis.

Authors:  Maura K Whiteman; Susan D Hillis; Kathryn M Curtis; Jill A McDonald; Phyllis A Wingo; Polly A Marchbanks
Journal:  Obstet Gynecol       Date:  2004-07       Impact factor: 7.661

8.  Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.

Authors:  Ellen T Chang; Roger L Milne; Kelly-Anne Phillips; Jane C Figueiredo; Meera Sangaramoorthy; Theresa H M Keegan; Irene L Andrulis; John L Hopper; Pamela J Goodwin; Frances P O'Malley; Nayana Weerasooriya; Carmel Apicella; Melissa C Southey; Michael L Friedlander; Graham G Giles; Alice S Whittemore; Dee W West; Esther M John
Journal:  Breast Cancer Res Treat       Date:  2008-11-26       Impact factor: 4.872

9.  Prognosis of premenopausal breast cancer and childbirth prior to diagnosis.

Authors:  Kelly-Anne Phillips; Roger L Milne; Michael L Friedlander; Mark A Jenkins; Margaret R E McCredie; Graham G Giles; John L Hopper
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

10.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.

Authors:  Esther M John; John L Hopper; Jeanne C Beck; Julia A Knight; Susan L Neuhausen; Ruby T Senie; Argyrios Ziogas; Irene L Andrulis; Hoda Anton-Culver; Norman Boyd; Saundra S Buys; Mary B Daly; Frances P O'Malley; Regina M Santella; Melissa C Southey; Vickie L Venne; Deon J Venter; Dee W West; Alice S Whittemore; Daniela Seminara
Journal:  Breast Cancer Res       Date:  2004-05-19       Impact factor: 6.466

View more
  15 in total

1.  Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.

Authors:  Marilyn L Kwan; Philip S Bernard; Candyce H Kroenke; Rachel E Factor; Laurel A Habel; Erin K Weltzien; Adrienne Castillo; Erica P Gunderson; Kaylynn S Maxfield; Inge J Stijleman; Bryan M Langholz; Charles P Quesenberry; Lawrence H Kushi; Carol Sweeney; Bette J Caan
Journal:  J Natl Cancer Inst       Date:  2015-04-28       Impact factor: 13.506

2.  Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry.

Authors:  Theresa H M Keegan; Roger L Milne; Irene L Andrulis; Ellen T Chang; Meera Sangaramoorthy; Kelly-Anne Phillips; Graham G Giles; Pamela J Goodwin; Carmel Apicella; John L Hopper; Alice S Whittemore; Esther M John
Journal:  Breast Cancer Res Treat       Date:  2010-02-07       Impact factor: 4.872

3.  Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species.

Authors:  Jenean O'Brien; Traci Lyons; Jenifer Monks; M Scott Lucia; R Storey Wilson; Lisa Hines; Yan-gao Man; Virginia Borges; Pepper Schedin
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

4.  Pregnancy-associated breast cancer: an entity needing refinement of the definition.

Authors:  Virginia F Borges; Pepper J Schedin
Journal:  Cancer       Date:  2011-11-15       Impact factor: 6.860

5.  Oral contraceptive use and survival in women with invasive breast cancer.

Authors:  Yani Lu; Huiyan Ma; Kathleen E Malone; Sandra A Norman; Jane Sullivan-Halley; Brian L Strom; Michael S Simon; Polly A Marchbanks; Jill A McDonald; Dee W West; Katherine D Henderson; Dennis Deapen; Giske Ursin; Leslie Bernstein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-06       Impact factor: 4.254

6.  Impact of Time Since Last Childbirth on Survival of Women with Premenopausal and Postmenopausal Breast Cancers.

Authors:  Nanthini Balakrishnan; Soo-Hwang Teo; Siamala Sinnadurai; Nanthini Thevi Bhoo Pathy; Mee-Hoong See; Nur Aishah Taib; Cheng-Har Yip; Nirmala Bhoo Pathy
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

7.  Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study.

Authors:  Avonne E Connor; Kala Visvanathan; Kathy B Baumgartner; Richard N Baumgartner; Stephanie D Boone; Lisa M Hines; Roger K Wolff; Esther M John; Martha L Slattery
Journal:  Breast Cancer Res Treat       Date:  2016-11-11       Impact factor: 4.872

8.  The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival.

Authors:  Anna H Wu; Scarlett Lin Gomez; Cheryl Vigen; Marilyn L Kwan; Theresa H M Keegan; Yani Lu; Salma Shariff-Marco; Kristine R Monroe; Allison W Kurian; Iona Cheng; Bette J Caan; Valerie S Lee; Janise M Roh; Jane Sullivan-Halley; Brian E Henderson; Leslie Bernstein; Esther M John; Richard Sposto
Journal:  Cancer Causes Control       Date:  2013-07-18       Impact factor: 2.506

9.  Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.

Authors:  Xuezheng Sun; Hazel B Nichols; Chiu-Kit Tse; Mary B Bell; Whitney R Robinson; Mark E Sherman; Andrew F Olshan; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-06       Impact factor: 4.254

10.  Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.

Authors:  Anna Morra; Audrey Y Jung; Marjanka K Schmidt; Jenny Chang-Claude; Sabine Behrens; Renske Keeman; Thomas U Ahearn; Hoda Anton-Culver; Volker Arndt; Annelie Augustinsson; Päivi K Auvinen; Laura E Beane Freeman; Heiko Becher; Matthias W Beckmann; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Hermann Brenner; Ignacio Briceno; Sara Y Brucker; Nicola J Camp; Daniele Campa; Federico Canzian; Jose E Castelao; Stephen J Chanock; Ji-Yeob Choi; Christine L Clarke; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Thilo Dörk; Alison M Dunning; Miriam Dwek; Douglas F Easton; Diana M Eccles; Kathleen M Egan; D Gareth Evans; Peter A Fasching; Henrik Flyger; Manuela Gago-Dominguez; Susan M Gapstur; José A García-Sáenz; Mia M Gaudet; Graham G Giles; Mervi Grip; Pascal Guénel; Christopher A Haiman; Niclas Håkansson; Per Hall; Ute Hamann; Sileny N Han; Steven N Hart; Mikael Hartman; Jane S Heyworth; Reiner Hoppe; John L Hopper; David J Hunter; Hidemi Ito; Agnes Jager; Milena Jakimovska; Anna Jakubowska; Wolfgang Janni; Rudolf Kaaks; Daehee Kang; Pooja Middha Kapoor; Cari M Kitahara; Stella Koutros; Peter Kraft; Vessela N Kristensen; James V Lacey; Diether Lambrechts; Loic Le Marchand; Jingmei Li; Annika Lindblom; Jan Lubiński; Michael Lush; Arto Mannermaa; Mehdi Manoochehri; Sara Margolin; Shivaani Mariapun; Keitaro Matsuo; Dimitrios Mavroudis; Roger L Milne; Taru A Muranen; William G Newman; Dong-Young Noh; Børge G Nordestgaard; Nadia Obi; Andrew F Olshan; Håkan Olsson; Tjoung-Won Park-Simon; Christos Petridis; Paul D P Pharoah; Dijana Plaseska-Karanfilska; Nadege Presneau; Muhammad U Rashid; Gad Rennert; Hedy S Rennert; Valerie Rhenius; Atocha Romero; Emmanouil Saloustros; Elinor J Sawyer; Andreas Schneeweiss; Lukas Schwentner; Christopher Scott; Mitul Shah; Chen-Yang Shen; Xiao-Ou Shu; Melissa C Southey; Daniel O Stram; Rulla M Tamimi; William Tapper; Rob A E M Tollenaar; Ian Tomlinson; Diana Torres; Melissa A Troester; Thérèse Truong; Celine M Vachon; Qin Wang; Sophia S Wang; Justin A Williams; Robert Winqvist; Alicja Wolk; Anna H Wu; Keun-Young Yoo; Jyh-Cherng Yu; Wei Zheng; Argyrios Ziogas; Xiaohong R Yang; A Heather Eliassen; Michelle D Holmes; Montserrat García-Closas; Soo Hwang Teo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-01-26       Impact factor: 4.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.